# Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

> **NCT00005035** · PHASE2 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center**

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00005035
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005035, "Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00005035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*